Ben Sasse is "on extended time." The former Republican U.S. senator from Nebraska was diagnosed with stage 4 metastatic pancreatic cancer in December and was told he had three or four months to live. He credits "providence, prayer and a miracle drug" — a clinical trial that has shrunk his tumors by 76% — for buying him more time. Patients who typically would have had about six months to live are living around 13 months with Revolution Medicines' daraxonrasib.  Sasse talked at length about his